EdgeMarketInstruments › IVVD

IVVD — Invivyd, Inc.

US Healthcare Pharma & biotech equity mkt cap 280.3M
1.00 +4.81% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.52 · high 2.88

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-08-06.

Performance

1 day+4.81%
1 week+38.23%
1 month+63.58%
3 months-10.23%
6 months-35.71%
Year to date-60.14%
1 year+57.23%
3 years-39.97%
5 years-96.26%

Technicals

RSI 1482.3
vs 50-day avg+28.74%
vs 200-day avg-35.25%
Volatility 1y142.6%
Max drawdown 1y-81.42%
Avg volume 30d3.4M
Daily bars held1,266
History from2021-08-06

Measured signals that fired on IVVD

datesignal measured base rate
2026-07-27Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-06-26Volume shock without a price move
price
-1.33% over 21 days · t = -4.53 · n = 16,432
statistically distinguishable from its control group
2026-06-05Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-04-10Volume shock without a price move
price
-1.33% over 21 days · t = -4.53 · n = 16,432
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-18Andersen Jill
Chief Legal Officer, Secretary
Open-market sale 10b5-1 plan30.7K0.8425.9K
2026-08-18Green Julie
Chief Human Resources Officer
Open-market sale 10b5-1 plan18.4K0.8415.5K
2026-08-18Lee Timothy Edward
Chief Commercial Officer
Open-market sale 10b5-1 plan18.4K0.8415.5K
2026-08-18Duke William E.
Chief Financial Officer
Open-market sale 10b5-1 plan18.4K0.8415.5K
2026-08-18Allen Robert D. III
Chief Scientific Officer
Open-market sale 10b5-1 plan17.0K0.8414.4K
2026-08-17Andersen Jill
Chief Legal Officer, Secretary
Open-market sale 10b5-1 plan37.3K0.7226.9K
2026-08-17Lee Timothy Edward
Chief Commercial Officer
Open-market sale 10b5-1 plan22.4K0.7216.1K
2026-08-17Green Julie
Chief Human Resources Officer
Open-market sale 10b5-1 plan22.4K0.7216.1K
2026-08-17Duke William E.
Chief Financial Officer
Open-market sale 10b5-1 plan22.4K0.7216.1K
2026-08-17Allen Robert D. III
Chief Scientific Officer
Open-market sale 10b5-1 plan20.7K0.7214.9K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
JANUS HENDERSON GROUP PLC42.9M33.1M
PERCEPTIVE ADVISORS LLC27.1M20.9M
BVF INC/IL25.4M19.5M
MAVERICK CAPITAL LTD24.7M19.0M
Saturn V Capital Management LP14.2M10.9M
VANGUARD CAPITAL MANAGEMENT LLC13.1M10.1M
M28 Capital Management LP12.0M9.2M
EVENTIDE ASSET MANAGEMENT, LLC11.8M9.1M
Driehaus Capital Management LLC11.0M8.4M
Soleus Capital Management, L.P.10.0M7.7M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d47.6% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about IVVD

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open IVVD in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →